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Purpose: There are a high number of HIV-infected patients receiving antiretroviral therapy 
(ART) in the Kathmandu District of Nepal, but information on adherence and factors influ-
encing it are scarce in this population. The present study aimed to estimate ART adherence 
among HIV-infected patients in the Kathmandu District of Nepal, and to determine the factors 
associated with ART adherence.
Patients and methods: This study included 316 HIV-infected patients attending three ART 
centers in the Kathmandu District. Information on sociodemographic characteristics, socioeco-
nomic status, and ART use for the previous 7 days was collected via interview. Participants were 
considered adherent if they reported taking $95% of their ART as prescribed. The association 
between explanatory variables and ART adherence was measured using logistic regression and 
reported as odds ratios (OR) with 95% confidence intervals (CI).
Results: Male participants accounted for 64.6% (n=204). Overall ART adherence was 86.7%. 
ART adherence in men and women were 84.3% and 91.1%, respectively. Age (OR 1.04; 
95% CI 1.00–1.09), travel time to ART centers (OR 1.38; 95% CI 1.12–1.71), history of illegal 
drug use (OR 3.98; 95% CI 1.71–9.24), and adverse effects (OR 4.88; 95% CI 1.09–21.8), 
were all independently and negatively associated with ART adherence. Use of reminder 
tools (OR 3.45; 95% CI 1.33–8.91) was independently and positively associated with ART 
adherence.
Conclusion: The observed ART adherence in this study is encouraging. Travel time to ART 
centers, self-reported adverse effects, illegal drug use, and not using reminder tools were the 
major determinants of ART adherence. Interventions that take these factors into account could 
further improve ART adherence.
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Introduction
Antiretroviral therapy (ART) has played an important role in improving the prognosis 
and quality of life of HIV/AIDS patients, and in reducing the rate of disease progres-
sion and death.1–3 It has also been reported that increased access to ART can reduce 
the risk of HIV transmission to sexual partners by 96%.4
ART adherence is a primary determinant of the effectiveness of this treatment, 
and is also considered a major predictor of survival among patients living with HIV/
AIDS.5 More than 95% adherence to ART is required in order to prevent the emer-
gence of resistant HIV strains, obtain long-term HIV suppression, reduce destruction 
of CD4 cells, increase survival, and improve quality of life.6,7 However, poor ART 
adherence can create a dangerous public health problem and limit the effectiveness 





of available HIV treatments.8 Poor ART adherence also 
leads to increased hospitalization rates, increased health 
care costs, reduced productivity, disruption of families 
and communities, and morbidity and mortality in low- and 
middle-income countries.9 Moreover, second-line ART 
regimens can be up to six times more expensive than first-
line regimens.10 As some patients still show poor ART 
adherence, this factor remains a major obstacle in the fight 
against HIV/AIDS.2,7 Maintaining optimal ART adherence 
over a long period of time also poses significant challenges 
for both patients and health care providers.9
Factors affecting ART adherence include patient char-
acteristics, ART regimen, clinical setting, social and envi-
ronmental factors, and the relationship between patients and 
their health care providers.6 Despite fears to the contrary, 
ART adherence is high among patients in some low- and 
middle-income countries.11,12
HIV is a concentrated epidemic in Nepal, with an overall 
prevalence of 0.30% in the population aged 15–49 years.13,14 
In 2011, approximately 50,200 adults and children were liv-
ing with HIV in Nepal, of whom 28.5% were women and 
58% were men of reproductive age.14 The Government of 
Nepal started free ART and counseling services in 2004,15 
and by July 2012 ART coverage had increased to 26.1% 
(6,642 adults and 500 children) of 27,363 HIV-infected 
patients eligible for ART (CD4 #350) at 39 ART centers in 
33 different districts.16
There are several ART regimens available in Nepal with 
acceptable antiretroviral potency. Generally, zidovudine 
(ZDV)/lamivudine (3TC)/neverapine (NVP), ZDV/3TC/ 
efavirenz (EFV), tenofovir disoproxil fumarate (TDF)/3TC/
NVP, TDF/3TC/EFV, stavudine (d4T)/3TC/EFV, and 
d4T/3TC/NVP are used as f irst-line regimens, while 
TDF/3TC/lopinavir boosted with ritonavir and didanosine/
abacavir/lopinavir boosted with ritonavir are commonly 
used as the second-line regimens.15 Previous studies in 
Nepal reported 85.5% ART adherence among attendees of 
10 ART centers located in different districts,17 79% ART 
adherence at the Tribhuvan University Teaching Hospital 
in Kathmandu,18 and 84% ART adherence in the far west 
of Nepal.19
Despite the high number of HIV-infected patients receiv-
ing ART in the Kathmandu District of Nepal, information on 
ART adherence and factors influencing adherence is lacking 
in this population. The present study aimed to estimate ART 
adherence among HIV-infected patients attending three ART 
centers in the Kathmandu District, and to determine the fac-
tors associated with ART adherence.
Materials and methods
Study settings and study population
The Kathmandu District has six ART centers. A multi-
site cross-sectional study was conducted at three of them 
in January to February 2012: the Sukaraj Tropical and 
 Infectious Disease Hospital, Bir Hospital, and the  Tribhubhan 
 University Teaching Hospital. The numbers of patients regis-
tered and receiving ART across these three centers was 2,240, 
102, and 114, respectively. All patients aged 18 years or 
older who had received ART therapy for at least 3 months 
prior to study enrollment and were able to give informed 
consent were eligible for inclusion in the study. A sample 
size of 316 patients was calculated using formulas described 
previously,20,21 in order to estimate ART adherence with a 
relative precision of 5%. The number of patients included 
from each ART center was based on the proportion of patients 
registered and receiving ART therapy at each center.
Ethical approval was obtained from the Nepal Health 
Research Council and the National Center for AIDS and 
STD Control. All participants signed a written informed 
consent form.
Data collection and variables of interest
Eligible patients were interviewed for 15–20 minutes by the 
first author and two ART counselors. The questionnaire used 
in the present study was adapted from an earlier study,22 with 
slight modifications to fit the norms in Nepal. The question-
naire was translated into Nepali and verified by a second 
translator. The questionnaire was used to collect sociodemo-
graphic information, personal history of ART adherence, and 
socioeconomic status. Patients’ medical records were used to 
collect information on CD4 cell counts and ART regimen.
Assessment of adherence
Adherence was assessed by asking patients to recall their intake 
of prescribed ART doses in the previous 7 days. In an attempt 
to minimize recall bias, patients were asked about adherence 
over the previous day, previous 3 days, and previous 7 days. 
Self-reported ART adherence was calculated as the ratio of the 
doses taken during the specific time-period to the total number 
of ART doses prescribed for the same time-period. The results 
were expressed as percentages. Patients were considered adher-
ent if they reported taking 95–100% of their prescribed ART 
with a delay of no more than 1 hour in the previous 7 days.
Statistical analysis
The information collected from patients was sorted, coded, 
and entered in a datasheet created in SPSS version 16 
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(SPSS Inc., Chicago, IL, USA). A double-data entry system 
was used to minimize errors in data entry. The explanatory 
variables were categorized as follows: age (continuous 
variable), sex (male/female), marital status (unmarried/
ever-married), educational level (literate/illiterate), occupa-
tion (employed/unemployed), monthly income (tertiles), 
travel time to ART centers (continuous variable), alcohol 
use in the month preceding the interview (yes/no), illegal 
drug use in the 6 months preceding the interview (yes/no), 
and use of reminder tools to take ART (yes/no). The clinical 
characteristics included the latest available CD4 cell count 
(.200/#200 cells/mm3), ART initiation (,24/$24 months), 
adverse effects (yes/no), and the number of tablets taken daily 
(continuous variable).
Differences between adherent and non-adherent patients 
were tested using the Student’s t-test and the chi-square 
test for continuous and categorical explanatory variables, 
respectively. The strength of association between explana-
tory variables and ART adherence was measured using 
logistic regression and was reported as odds ratios (OR) 
with 95% confidence intervals (CI). The OR associated with 
each explanatory variable was calculated first in a univariate 
model, then in an age- and sex-adjusted model, and finally in 
a multivariate model including all the variables. The variables 
with significant or borderline significant associations in the 
multivariate model were included in the final model. The 
criterion for statistical significance was set at P,0.05.
Results
Of the 316 participants, 64.6% (n=204) were men and 35.4% 
(n=112) were women. Most of the participants (n=308) 
were receiving standard first-line ART regimens. A total of 
274 (86.7%) participants reported ART adherence, and of 
these, 268 claimed not to have missed a single dose. On the 
other hand, 42 (13.3%) participants reported non-adherence. 
The most frequently cited reasons for non-adherence were 
“simply forgot” (80%) and “busy schedule” (19%). Other 
reported reasons for non-adherence included being too sick 
(11%), to hide their status from their family and friends 
(4.7%), or adverse effects (4.7%). These percentages over-
lapped as multiple responses were possible.
Table 1 shows the sociodemographic and clinical charac-
teristics of the study sample by adherence status. Only travel 
time to ART centers (P,0.001), alcohol use (P=0.026), 
illegal drug use (P=0.017), self-reported adverse effects 
(P=0.005), and use of reminder tools (P,0.001) were sig-
nificantly associated with adherence status. Almost 90% of 
the participants reported using some kind of reminder tool to 
Table 1 Sociodemographic and clinical characteristics of HIV-
infected patients in the Kathmandu District by ART adherence 
status, 2012







 18–24 44 41 (93.0) 3 (7.0) 0.270
 25–34 87 78 (89.6) 9 (10.4)
 35–49 148 125 (84.4) 23 (15.6)
 .50 37 30 (81.0) 7 (19.0)
Sex
 Male 204 172 (84.3) 32 (15.6) 0.091
 Female 112 102 (91.1) 10 (8.92)
Marital status
 Unmarried 68 59 (86.7) 9 (13.3) 0.945
 Married 154 135 (87.6) 19 (12.4)
 Divorced 29 25 (86.2) 4 (13.4)
 Widow/widowers 65 55 (84.6) 10 (15.4)
education level
 Illiterate 56 48 (85.7) 8 (14.3) 0.848
 Primary education 85 71 (83.5) 14 (16.5)
 Secondary education 99 88 (88.8) 11 (11.2)
 Higher secondary 61 54 (88.5) 7 (11.5)
 University level 15 13 (86.6) 2 (13.4)
Residence (region of Kathmandu)
 Inside valley 137 120 (87.5) 17 (12.5) 0.686
 Outside valley 179 154 (86) 25 (14)
Occupation
 Unemployment 71 58 (81.6) 13 (18.4) 0.717
 Agriculture 95 83 (87.3) 12 (12.7)
 labor work 53 46 (86.7) 7 (13.3)
 Business 68 60 (88.2) 8 (11.8)
  Office work 26 24 (92.3) 2 (7.7)
 Student 3 3 (100) 0 (0)
Monthly income
 lowest tertile 99 83 (83.8) 16 (16.2) 0.054
 Middle tertile 107 93 (86.9) 14 (13.1)
 Highest tertile 110 98 (89.1) 12 (10.9)
Family size
 nuclear 208 158 (75.9) 50 (24.1) 0.746
 Joint 115 88 (23.5) 27 (76.5)
 live alone 92 70 (76.0) 22 (23.0)
Mode of transmission
 Heterosexual 242 212 (87.6) 30 (12.3) 0.947
 Shared needle 40 34 (85.0) 6 (15.0)
 Blood transfusion 12 9 (75.0) 3 (25.0)
 Unknown 22 19 (86.3) 3 (13.7)
Cost of travel to ART center
 lowest tertile 111 103 (92.7) 8 (7.2) 0.054
 Middle tertile 99 84 (84.8) 15 (15.2)
 Highest tertile 106 87 (82.0) 19 (18.0)
Travel time to ART center (minutes)
 #60 173 161 (93.0) 12 (7.0) 0.000
 .60 143 113 (79.0) 30 (21.0)
Alcohol usea
 no 268 238 (88.8) 30 (11.2) 0.026
 Yes 48 36 (75) 12 (25)
(Continued)





take the medicine at the correct time (Table 1). Some of the 
most widely used reminder tools were mobile alarm, watch, 
and support from family members.
A total of 248 (78.5%) participants reported differ-
ent health complaints that occurred in the month before 
interview, which could have been caused by either the HIV 
infection, or the ART (Table 2). Dizziness, skin rash, and 
vomiting were significantly more frequently reported among 
non-adherent participants (P,0.005).
In univariate analyses (Table 3), non-adherence was 
significantly associated with the travel time to ART cen-
ters, alcohol use, illegal drug use, adverse effects, cost 
Table 2 Distribution of health complaints among HIV-infected 
patients receiving ART in the Kathmandu District, 2012
Health complaints N* (%) P-value**
Itching 72 (22.8%) 0.433
Headache 43 (13.6%) 0.395
Dizziness 40 (12.7%) 0.002
Skin rash 39 (12.3%) 0.000
Vomiting 39 (12.3%) 0.008
Fatigue 34 (10.8%) 0.838
Prolonged fever 32 (10.1%) 0.185
Arthritis 23 (7.3%) 0.500
Persistent cough 17 (5.4%) 0.438
Anemia 16 (5.1%) 0.395
Pain and numbness 15 (4.7%) 0.433
Diarrhea 10 (3.2%) 0.525
Others 13 (4.1%) 0.725
Insomnia 9 (2.8%) 0.845
Notes: *number overlap (participants could report more than one reason); 
**comparing frequency between adherent and non-adherent participants.
Abbreviation: ART, antiretroviral therapy.
Table 1 (Continued)







 Yes 43 27 (62.7) 16 (37.3) 0.017
 no 273 247 (90.4) 26 (9.6)
Reminder toolsc
 Yes 287 257 (89.5) 30 (10.5) 0.000
 no 29 17 (58.6) 12 (41.4)
ART initiation (month)
 ,24 166 148 (89.1) 18 (10.9) 0.178
 $24 150 126 (84.0) 24 (16.0)
CD4 cell countd (cells/mm3)
 ,200 56 44 (78.5) 12 (21.6) 0.193
 200–350 148 130 (87.8) 18 (12.2)
 .350 99 87 (87.8) 12 (12.2)
Adverse effects
 Yes 248 208 (83.8) 40 (16.2) 0.005
 no 68 66 (97.0) 2 (3.0)
number of tablets per day
 #3 237 202 (85.3) 35 (14.7) 0.180
 .3 79 72 (91.1) 7 (8.9)
Notes: *Row percentage; aalcohol use: alcohol use in past 1 month; billegal drug use: 
illegal drug use in past 6 months prior to study; creminder tools: use of any reminder 
tool to take ART; dCD4 count: latest available CD4 cell count.
Abbreviation: ART, antiretroviral therapy.
Table 3 Factors associated with non-adherence (univariate 
and age- and sex-adjusted) among HIV-infected patients in the 
Kathmandu District, 2012
Variables Crude OR  
(95% CI)
Age and sex adjusted 
OR (95% CI)
Age 1.03 (1.0–1.07) 1.03 (0.99–1.07)
Sex
 Male 1.89 (0.89–4.02) 1.87 (0.88–3.99)
 Female 1 1
Marital status
 ever married 1.00 (0.45–2.22) 0.62 (0.24–1.54)
 Unmarried 1 1
education level
 Illiterate 1.10 (0.48–2.54) 1.23 (0.52–2.86)
 literate 1 1
Occupation
 Unemployed 1.56 (0.76–3.19) 1.68 (0.81–3.47)
 employed 1 1
Income
 lower tertile 1.57 (0.70–3.51) 1.81 (0.79–4.10)
 Middle tertile 1.22 (0.54–2.79) 1.32 (0.57–3.04)
 Higher tertile 1 1
Family
 Without family 1.29 (0.61–2.72) 1.11 (0.52–2.38)
 With family 1
Cost of travel to ART center
 lower tertile 0.35 (0.14–0.85) 0.33 (0.14–0.82)
 Middle tertile 0.81 (0.39–1.71) 0.73 (0.34–1.57)
 Higher tertile 1
Travel time to  
ART center
1.34 (1.13–1.61) 1.39 (1.16–1.67)
Alcohol use
 Yes 2.64 (1.24–5.63) 2.76 (1.27–5.96)
 no 1 1
Illegal drug use
 Yes 5.6 (2.68–11.78) 5.29 (2.49–11.24)
 no 1 1
Use of reminder tools
 no 6.04 (2.63–13.86) 6.04 (2.59–14.09)
 Yes 1 1
ART initiation (month)
 $24 1.56 (0.81–3.01) 1.24 (0.60–2.57)
 ,24 1
CD4 cell count (cells/mm3)
 #200 1.82 (0.86–3.81) 1.89 (0.89–4.01)
 .200 1 1
Adverse effects
 Yes 6.34 (1.49–26.97) 6.99 (1.63–29.98)
 no 1 1
number of tablets per day
 .3 0.97 (0.59–1.59) 0.96 (0.59–1.56)
 #3 1 1
Abbreviations: OR, odds ratio; CI, confidence interval; ART, antiretroviral therapy.
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of travel to ART centers, and no use of reminder tools. 
A borderline significant association was observed with 
age. After adjusting for age and sex, the same variables 
remained significantly associated with non-adherence, 
and the adjusted ORs were almost unchanged. The final 
multivariate model included age, sex, travel time to ART 
centers, alcohol use, illegal drug use, adverse effects, and 
use of reminder tools (Table 4). A 1-year increase in age 
increased the odds of non-adherence by 4% (OR 1.04; 95% 
CI 1.00–1.09). An increase in travel time to ART centers 
of 1 hour was associated with a 38% increase in the odds 
of being non-adherent (OR 1.38; 95% CI 1.12–1.71). On 
the other hand, the odds of being non-adherent among 
participants with a history of illegal drug use was almost 
four times that of participants without a history of illegal 
drug use (OR 3.98; 95% CI 1.71–9.24), and the odds of 
non-adherence were highly increased in participants who 
reported adverse effects (OR 4.88; 95% CI 1.09–21.8). The 
odds of being non-adherent among participants who did not 
use reminder tools were 3.45 times those of participants who 
did use a reminder tool (OR 3.45; 95% CI 1.33–8.91).
Discussion
To our knowledge, this is the first multi-site study to assess 
the factors associated with ART adherence among HIV-
infected patients receiving free ART at ART centers in the 
Kathmandu District of Nepal. The overall self-reported 
ART adherence level for 1 week was 86.7%. Time taken 
to reach ART centers, self-reported adverse effects, illegal 
drug use, and not using reminder tools present barriers to 
ART adherence.
ART adherence in this study is consistent with previous, 
similar studies in Nepal, and is comparable to self-reported 
ART adherence in several other low- and middle-income 
countries.3,17,19,20 The slightly higher ART adherence in this 
study might be due the assessment of 7-day adherence. It 
is also possible that adherent patients are more likely to 
attend their outpatient appointments, and thus more likely 
to be included in this study sample. However, the 13% non-
adherence observed in the present study constitutes a serious 
problem in a resource-limited country like Nepal, as the 
development of treatment resistance will lead to increased 
hospitalization rates, increased health care costs, reduced 
productivity, disruption of families and communities, and 
increased morbidity and mortality. The main reasons par-
ticipants gave for non-adherence were simply forgetting to 
take ART and having a busy schedule, which is in accordance 
with previous findings.12,19,23,24
The proportion of men in this study sample was 
 approximately two-fold that of women, which is similar 
to the proportion of HIV/AIDS cases reported in Nepal.14 
Sex and marital status did not significantly affect ART 
adherence. This f inding is in agreement with studies 
elsewhere,12,20,23 but in contrast to a previous study in Nepal,17 
in which HIV-infected women were less likely to adhere to 
ART.  Nevertheless, HIV-infected women in most low- and 
middle-income countries face several social, psychologi-
cal, economical, and biological challenges which impact 
their ability to take medication. Therefore, the challenge 
to improve access to ART and ART adherence in women 
remains critical in these countries.3
The present study shows that ART adherence decreased 
significantly with increasing age. However, this finding 
contrasts with a study by Barclay et al, which showed that 
patients aged less than 50 years were two times more likely to 
be non-adherent,25 and with studies that showed no associa-
tion between age and ART adherence.17,19,24,26 Such variations 
could be related to differences between studies in terms of 
population sampling. Indeed, the number of persons aged 
50 years and older living with HIV/AIDS is increasing due to 
ART.27 Therefore, the influence of age may change over time 
and needs to be further elucidated. The results of this study 
provide evidence that difficult access to ART in the form of 
long travel time to ART centers can hinder ART adherence 
among HIV-infected patients in resource-limited countries. 
In accordance with this, two Indian studies20,23 and two 
Table 4 Factors associated with non-adherence (final multivariate 
model) among 316 HIV-infected patients in the Kathmandu 
District, 2012




 Male 2.19 (0.92–5.25)
 Female 1
Travel time to ART center 1.38 (1.12–1.71)
Alcohol use
 Yes 2.26 (0.93–5.44)
 no 1
Illegal drug use
 Yes 3.98 (1.71–9.24)
 no 1
Adverse effects
 Yes 4.88 (1.09–21.80)
 no 1
Use of reminder tools
 no 3.45 (1.33–8.91)
 Yes 1
Abbreviations: OR, odds ratio; CI, confidence interval; ART, antiretroviral therapy.





 African studies12,24 showed that traveling from distant places 
to ART centers was one of the barriers to ART adherence. It 
has been reported that, despite the extension of ART centers 
into different regions of Nepal, people living with HIV are 
unwilling to seek treatment at the nearest health institution 
due to fear of stigmatization.17 In such situations, patients 
may choose to travel long distances to seek ART services, 
which may ultimately lead to less ART adherence because of 
time constraints. In Nepal, traveling long distances to receive 
treatment is common, and not surprisingly, transportation 
difficulties have often been reported to be a major hindrance 
to ART adherence.3
Health complaints such as dizziness, skin rash, and 
vomiting were more frequently reported by non-adherent 
than adherent participants. This study shows that health 
complaints due to HIV infection, or as an adverse effect of 
ART, are associated with non-adherence. This is consistent 
with findings of several other studies.17,19,24 In addition, one 
meta-analysis showed that varying from mild to severe 
and from acute to chronic, adverse effects and toxicity of 
the complex ART drugs was an important reason for non-
adherence.28 The management of symptoms is a vital part of 
successful ART adherence. Hence, it is necessary to discuss 
all potential adverse effects with patients before they begin 
ART. Moreover, each patient must be assessed individually 
for readiness to adhere to complex ART regimens.28
In contrast to previous findings,28 this study found no 
significant independent association between alcohol use and 
ART adherence. On the other hand, the high odds of non-
adherence among participants with a history of illegal drug 
use are in agreement with previous studies.3,29–31 Patients with 
a history of substance use are significantly less engaged with 
their health care provider, and are likely to exhibit a higher 
rate of treatment refusal.6,28 Furthermore, psycho-social 
problems can be additional factors related to non-adherence 
among illegal drug users.
This study illustrates the strong association between the 
use of reminder tools and ART adherence. This supports ear-
lier findings of 4.2-fold greater risk of non-adherence among 
patients who did not use any reminder tool.8 In a review of 
ART adherence, Mills et al showed that reminders in the form 
of support from friends and family facilitates successful ART 
adherence.32 In addition, disclosing one’s HIV status to others 
had a positive influence on adherence.3,28
Although many other potential variables were included 
in this study, they did not show consistent associations 
with ART adherence. The number of tablets taken per day 
was not associated with ART adherence in univariate or 
multivariate analysis. However, several other studies have 
shown that ART adherence decreases with an increasing num-
ber of tablets and number of daily doses.20,33  Nevertheless, 
various studies reported that despite new ART regimens 
with fewer tablets and daily doses, adherence remains a 
problem.7,33 Objective tools such as pill count, electronic 
pill caps, and other biological methods are needed in the 
evaluation of the association between the number of tablets 
and ART adherence.
Similar to previous studies,17,19,34 no significant associa-
tions were found between education level, income, marital 
status, and adherence. Moreover, similar to most,23,24,33 but 
not all20 previous studies, the present study showed no sig-
nificant association between the time since initiating ART 
and non-adherence.
ART adherence varies over time and between  individuals. 
Therefore, using multiple measures, prospective and mixed 
studies, including qualitative and quantitative research 
from delivery sites run by both the public and private 
 sector, are needed to assess the factors associated with ART 
adherence.
Strengths and limitations
The strengths of the study include the relatively large and rep-
resentative sample of HIV-infected patients. Adherence was 
assessed for the 7 days prior to interview so that participants 
could accurately recall their behavior, thereby minimizing 
the chance of recall bias.
The findings may not form an adequate basis for gen-
eralization due to the limitations: ART adherence was self-
reported, and was assessed in terms of missing doses during 
the previous 7 days. Other dimensions of ART adherence, 
such as whether participants took the ART in accordance 
with dietary instructions, were not explored. It should be 
mentioned that only patients who personally collected/
refilled their ART at ART centers were included; patients 
whose ART was delivered to their home by volunteers 
were not approached. On the other hand, there might be 
other confounding factors that were not taken into account 
in this study. Self-reported information might have been 
influenced by recall bias and the social desirability effect, 
ie, patients’ desire not to disclose non-adherence in order 
to present themselves as a good patient.35 However, self-
reported measures are commonly used in both research and 
clinical care because of their relatively low cost, ease of 
administration, and good correlation with indirect adherence 
measures, such as pill count.36 Furthermore, this is a cross-
sectional study, therefore the temporal relationship among 
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the variables studied is unknown, and a causal relationship 
cannot be established.
Conclusion
The ART adherence results in the present study are  encouraging. 
The findings suggest that travel time to ART centers, self-
reported adverse effects, and substance use present additional 
barriers to ART adherence. On the other hand, having reminder 
tools to take ART enhanced  adherence. Interventions on the 
individual and community levels, such as community care cen-
ters and home-based care, need to be expanded at the village or 
district level to overcome these barriers. Moreover, health care 
providers should give clear instructions and proper counseling 
to patients in order to manage side effects. Patients reporting 
a history of illegal drug use should be targeted to enhance 
ART adherence. The use of different electronic devices such 
as watch and mobile phone should be encouraged as reminder 
tools to enhance ART adherence.
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